Table 3. Univariate and multivariate Cox regression analysis of disease-free survival in GC patients.
| Variables | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| P value | HR | 95% | P value | HR | 95% | |
| Age (≤60 vs. >60) | 0.525 | 0.993 | 0.972–1.015 | 0.973 | 1.000 | 0.976–1.024 |
| Gender (Female vs. Male) | 0.001 | 2.441 | 1.418–4.203 | 0.013 | 2.016 | 1.160–3.502 |
| Tumor grade (G1 vs. G2 vs. G3) | 0.319 | 1.265 | 0.797–2.008 | 0.454 | 1.201 | 0.744–1.938 |
| Residual tumor (No vs. Yes) | <0.000 | 4.063 | 2.019–8.175 | 0.002 | 3.065 | 1.514–6.204 |
| Stage-Female (Stage I vs. Stage II vs. Stage III vs. Stage IV) | 0.029 | 2.224 | 1.087–4.547 | 0.486 | 1.185 | 0.735–1.912 |
| Stage-Male (Stage I vs. Stage II vs. Stage III vs. Stage IV) | 0.062 | 1.366 | 0.984–1.897 | |||
| Distant metastasis (No vs. Yes) | 0.521 | 1.477 | 0.449–4.858 | 0.764 | 1.225 | 0.325–4.618 |
| Lymph node metastasis (N0 vs. N1 vs. N2 vs. N3) | <0.000 | 1.480 | 1.200–1.825 | 0.002 | 1.406 | 1.137–1.738 |
| Depth of invasion (T1 vs. T2 vs. T3 vs. T4) | 0.503 | 1.105 | 0.826–1.478 | 0.578 | 0.914 | 0.666–1.255 |
| ERICH3-AS1 level (Low vs. High) | 0.017 | 1.206 | 1.035–1.406 | 0.006 | 1.243 | 1.063–1.452 |
Notes.
- CI
- confidence interval
- HR
- hazard ratio